Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

IGI Laboratories Inc (NYSE MKT LLC:IG)

During the Trading Day
8.03 +0.20 / +2.55%
As of 4:02pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.01 -0.02 / -0.25%
 
Volume: 100.00
SECTOR
Consumer Non-Durables
INDUSTRY
Household/Personal Care
MARKET CAP
$428.2M

Company Description

IGI Laboratories, Inc. develops, manufactures and markets topical formulations. The company sells generic topical pharmaceutical products under IGI label. It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets. The company's products are used in a wide range of applications from cosmetics and cosmeceuticals to the prescription treatment of conditions like dermatitis, psoriasis, and eczema. IGI Laboratories was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.

Contact Information

IGI Laboratories, Inc.
105 Lincoln Avenue
Buena New Jersey 08310
P:(856) 697-1441
Investor Relations:
18566974389363

Employees

Shareholders

Other institutional44.24%
Mutual fund holders27.25%
Individual stakeholders22.03%

Top Executives

Jason Grenfell-GardnerPresident, Chief Executive Officer & Director
Sanjay SamudreOperations Director
Jenniffer L. CollinsChief Financial Officer & Secretary
Thomas VandervortVice President-Business Development